$IPGP

SCHERBAKOV EUGENE A sold $260K of IPGP

SCHERBAKOV EUGENE A sold 3,048 shares of IPG PHOTONICS CORP (IPGP) at $85.30 ($0.26M total) on 2026-10-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · SCHERBAKOV EUGENE A
Published Oct 6, 2026, 8:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IPGP
Neutral
medium confidence
Mentioned
$IPGP
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IPGPNeutralLow
01

Why it matters

A small insider sale typically has limited market impact unless part of a larger trend.

02

Market read

The filing is a routine insider transaction with modest relevance for short-term traders.

03

What to watch

Potential upcoming corporate actions or personal liquidity needs not disclosed.

Relevance 3/10Novelty 3/10Timing: today

Background

Form 4 disclosures provide transparent insight into insider transactions.

Company-level read

Ticker impact

$IPGPNeutralMedium confidence
Context

Director Eugene Scherbakov sold 3,048 shares for $259,994, reducing his stake to 45,162 shares.

Expected impact

likely slight downward pressure as the market prices the insider sell.

Evidence & confidence

Form 4 filings are primary source; the transaction size (~$260K) is modest, so impact is limited.

Market effects

Minimal effect on the photonics sector; insider sales are routine.

None

Low

Counterpoint

The sale could be unrelated to fundamentals; investors may ignore it.

Key entities

  • Eugene Scherbakov

    Director and 10% owner of IPG Photonics Corp.

  • IPG Photonics Corp

    US-listed photonics equipment manufacturer (ticker IPGP).

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IPGPMedAI 8/10

Should IPG Photonics’ Q2 Earnings Beat And Tariff-Cautious Outlook Require Action From IPGP Investors?

IPG Photonics (IPGP) reported Q2 2026 adjusted earnings of $0.58 per share, beating expectations, with 11% YoY revenue growth driven by its Industrial Solutions segment. The company issued cautious Q3 guidance due to tariff uncertainty, but analyst estimates have recently increased. The company projects $1.4B revenue and $120M earnings by 2029, requiring 9.2% yearly revenue growth. A $100M share repurchase program is ongoing, though no shares were bought back in Q2. Tariff and trade risks remain

$IPGPMedAI 8/10

Why IPG Photonics Rallied Today

IPG Photonics (IPGP) shares rose 7.9% after the company reported mixed Q2 results and issued stronger-than-expected guidance. Revenue rose 11.1% to $278.6M, missing estimates, while adjusted EPS nearly doubled to $0.58. For Q3, IPG guided $280M revenue and $0.45 adjusted EPS at the midpoint.

$IPGPMed

IPG Photonics Q2 Earnings Call Highlights

IPG Photonics (IPGP) reported Q2 GAAP gross margin of 40.4% and adjusted gross margin of 40.7%, with GAAP diluted EPS of $0.12 and adjusted diluted EPS of $0.58. Management cited battery-manufacturing wins, additive manufacturing growth, and semiconductor momentum, plus CROSSBOW shipments for Lockheed Martin. IPG agreed to acquire Lumibird Medical, expected to close Q4 2026. Q3 revenue guidance is $265M to $295M.